WO2001079209A3 - Antagonistes des recepteurs d'il-8 a base de diazafluorenone - Google Patents
Antagonistes des recepteurs d'il-8 a base de diazafluorenone Download PDFInfo
- Publication number
- WO2001079209A3 WO2001079209A3 PCT/US2001/006817 US0106817W WO0179209A3 WO 2001079209 A3 WO2001079209 A3 WO 2001079209A3 US 0106817 W US0106817 W US 0106817W WO 0179209 A3 WO0179209 A3 WO 0179209A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- chemokine
- mammal
- diazafluorenone
- human
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001240021A AU2001240021A1 (en) | 2000-04-13 | 2001-03-01 | Diazafluorenone il-8 receptor antagonists |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19707300P | 2000-04-13 | 2000-04-13 | |
US60/197,073 | 2000-04-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001079209A2 WO2001079209A2 (fr) | 2001-10-25 |
WO2001079209A3 true WO2001079209A3 (fr) | 2002-05-16 |
Family
ID=22727926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/006817 WO2001079209A2 (fr) | 2000-04-13 | 2001-03-01 | Antagonistes des recepteurs d'il-8 a base de diazafluorenone |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001240021A1 (fr) |
WO (1) | WO2001079209A2 (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1296985B1 (fr) * | 2000-07-06 | 2005-06-01 | QLT Inc. | Inhibiteurs heteropolycycliques |
AU2003260072A1 (en) | 2002-08-27 | 2004-03-19 | Bristol-Myers Squibb Company | Antagonists of chemokine receptors |
EP1651226B1 (fr) * | 2003-07-11 | 2010-02-24 | Proteologics, Inc. | Inhibiteurs de l'ubiquitine ligase et methodes associees |
WO2007005403A1 (fr) | 2005-06-29 | 2007-01-11 | Schering Corporation | Oxadiazolopyrazines 5,6-di-substituées et thiadiazolopyrazines comme ligands récepteurs de cxc-chimiokine |
EP1798232A1 (fr) * | 2005-12-08 | 2007-06-20 | Hybrigenics S.A. | Inhibiteurs de la cysteine protease, compositions pharmaceutiques et applications therapeutiques |
WO2007066200A2 (fr) * | 2005-12-08 | 2007-06-14 | Hybrigenics Sa | Inhibiteurs innovants des cysteine-proteases, leurs compositions pharmaceutiques et leurs applications therapeutiques |
JP5543209B2 (ja) * | 2006-10-30 | 2014-07-09 | ヒブリジェニクス・エスアー | 新規のシステインプロテアーゼのテトラサイクリン阻害剤、その薬剤組成物および治療のためのその使用 |
EP1918292A1 (fr) * | 2006-10-30 | 2008-05-07 | Hybrigenics S.A. | Inhibiteurs tetracycliques de cysteine proteases, des compositions pharmaceutiques et leur utilisation therapeutique |
US7875613B2 (en) | 2006-10-30 | 2011-01-25 | Hybrigenics Sa | Tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
WO2012006104A2 (fr) * | 2010-06-28 | 2012-01-12 | Academia Sinica, Taiwan | Composés et procédés destinés au traitement d'une infection par la tuberculose |
WO2018067548A1 (fr) * | 2016-10-03 | 2018-04-12 | The Children's Medicial Center Corporation | Prévention et traitement de néphropathie diabétique |
JP2023549565A (ja) * | 2020-11-18 | 2023-11-27 | テキサス・テック・ユニバーシティー・システム | ral相互作用タンパク質に結合してこれを阻害する低分子を用いた癌の治療法 |
WO2023225558A1 (fr) * | 2022-05-17 | 2023-11-23 | Avesta76 Therapeutics, Inc. | Inhibiteurs de rlip76 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999042464A1 (fr) * | 1998-02-23 | 1999-08-26 | Warner-Lambert Company | ANTAGONISTES DU RECEPTEUR DE L'INTERLEUKINE-8 A BASE D'IMIDAZO[1,2-a;3,4-a']DIQUINOLINYLIUM SUBSTITUE |
WO1999042463A1 (fr) * | 1998-02-23 | 1999-08-26 | Warner-Lambert Company | Derives de quinoxaline substitues utilises comme antagonistes du recepteur de l'interleukine-8 |
-
2001
- 2001-03-01 WO PCT/US2001/006817 patent/WO2001079209A2/fr active Application Filing
- 2001-03-01 AU AU2001240021A patent/AU2001240021A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999042464A1 (fr) * | 1998-02-23 | 1999-08-26 | Warner-Lambert Company | ANTAGONISTES DU RECEPTEUR DE L'INTERLEUKINE-8 A BASE D'IMIDAZO[1,2-a;3,4-a']DIQUINOLINYLIUM SUBSTITUE |
WO1999042463A1 (fr) * | 1998-02-23 | 1999-08-26 | Warner-Lambert Company | Derives de quinoxaline substitues utilises comme antagonistes du recepteur de l'interleukine-8 |
Also Published As
Publication number | Publication date |
---|---|
AU2001240021A1 (en) | 2001-10-30 |
WO2001079209A2 (fr) | 2001-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL173032A0 (en) | Pyridazine derivatives and their use as therapeutic agents | |
IL173396A0 (en) | Piperazine derivatives and their use as therapeutic agents | |
WO2005011655A3 (fr) | Derives de pyridazine et leur utilisation en tant qu'agents therapeutiques | |
WO2001042231A3 (fr) | Traitement anti-inflammatoire et psoriasique et inhibition de la proteine kinase par des hydroxylstilbenes et de nouveaux derives de stilbene ou analogues | |
WO2001079209A3 (fr) | Antagonistes des recepteurs d'il-8 a base de diazafluorenone | |
IL188506A0 (en) | Use of an immunogen for preparation of pharmaceutical composition for treating alzheimer's disease | |
WO1997020823A3 (fr) | Antagonistes de recepteurs | |
WO2002057261A3 (fr) | Diaminothiazoles | |
EP2266569A3 (fr) | Dérivés hétérocycliques et leur utilisation en tant qu'inhibiteurs de la stearoyl-coa desaturase | |
WO2002080846A3 (fr) | Derives d'epothilone : procedes de fabrication et methodes d'utilisation associes | |
HUP9900950A3 (en) | Use of nicotine derivatives for producing pharmaceutical compositions suitable for treating inflammatory bowel disease | |
WO2006086447A3 (fr) | Derives de pyridazine et leur utilisation en tant qu'agents therapeutiques | |
HK1074046A1 (en) | Ccr1 antagonists for the treatment of i.a. demyelinating inflammatory disease | |
MX9703518A (es) | Dihidropirimidinas y usos de las mismas. | |
WO2001009118A3 (fr) | Composes dithiolthione pour le traitement de troubles neurologiques et pour renforcer la memoire | |
TNSN04165A1 (en) | Substituted hydroxyethylamines | |
MXPA04003439A (es) | Compuestos de maleimida 3,4 disustituidos como antagonistas de receptor de quimiocina cxc. | |
HUP0203437A3 (en) | Use of resorcinol derivatives for producing pharmaceutical compositions for treatment of immune diseases | |
WO1998051311A3 (fr) | Dihydropyrimidines et leurs utilisations | |
WO2003048164A3 (fr) | Antagonistes du recepteur a2a de l'adenosine | |
WO2001092283A3 (fr) | Composes de cobalamine utilises en tant qu'agents cardio-vasculaires et agents d'imagerie | |
WO2001035950A3 (fr) | Agent therapeutique a base d'amide et procedes de traitement des affections intestinales inflammatoires | |
CA2468649A1 (fr) | Antagonistes du recepteur a2a d'adenosine | |
WO2003011274A3 (fr) | Methode therapeutique | |
EP1398029A8 (fr) | Derivés de pyrazole,substitués en position 3 ayant une affinité envers le NR3B1 récepteur |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AU BA BB BG BR BZ CA CN CO CR CU CZ DM DZ EE GD GE HR HU ID IL IN IS JP KP KR LC LK LR LT LV MA MG MK MN MX MZ NO NZ PL RO SG SI SK SL TR TT UA US UZ VN YU ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AU BA BB BG BR BZ CA CN CO CR CU CZ DM DZ EE GD GE HR HU ID IL IN IS JP KP KR LC LK LR LT LV MA MG MK MN MX MZ NO NZ PL RO SG SI SK SL TR TT UA US UZ VN YU ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |